Clinical Trial Update: Epidiolex in Typical Absence Seizures [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Epidiolex for typical absence seizures has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typical Absence Seizures

Drugs mentioned

• EPIDIOLEX (Cannabidiol)

Snippet

Sponsor: University of South Florida | Conditions: Study the Efficacy of Epidiolex for Typical Absence Seizures | Phase 4 | Status: COMPLETED